© 2017 Dr. Ashutosh Singh

Designed by Y-Box Media

  • Facebook - White Circle
  • Twitter - White Circle
  • Google+ - White Circle
  • LinkedIn - White Circle
  • Tumblr - White Circle
  • Instagram - White Circle

Follow us on:

For Patients

Outreach Clinics

Sunday, May 26, 2019

By Dr. Ashutosh Singh, Consultant Psychiatrist, Apollo Hospital, Indore

Swiss drugmaker Novartis has received US approval for its spinal muscular atrophy gene therapy Zolgensma – pricing the one-time treatment at a record $2.125m.


The Food and Drug Administration on Frid...

Sunday, May 26, 2019

By Dr. Ashutosh Singh, Indore

The U.S. Food and Drug Administration  today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (e...

Please reload

Featured Posts

FDA permits marketing of first medical device for treatment of ADHD

May 26, 2019

1/1
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square